Brent Warner

Brent Warner is a biopharmaceutical executive with over 15 years of experience in the industry.1 He served as Vice President of Gene Therapy and Rare Disease at Novartis from October 2019 to February 2022.1 Currently, Warner is the President of Gene Therapy at Poseida Therapeutics, where he leads advancements in rare and genetic diseases, overseeing research and pre-clinical development of non-viral gene therapy programs and platform technologies.1

Warner's career includes significant roles in gene therapy and rare diseases:

• President of Gene Therapy at Poseida Therapeutics (February 2022 - Present)1
• Board Member at Cure Rare Disease (January 2023 - Present)1
• North America Launch Leader for Gene Therapy at BioMarin Pharmaceutical Inc. (March 2019 - October 2019)1
• Global Marketing roles at Biogen and PODS1

He holds an MBA with an emphasis in marketing and finance and a Bachelor of Business Administration degree, both from Northwood University in Michigan.1